Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28578607

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Jul 27
First author
Fizazi K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Jul 27;377(4):388-390. doi: 10.1056/NEJMe1704992.
    note
    Source null
    related pmid
    28745978
    relationship
    Comment in
  2. citation
    Urology. 2017 Nov;109:1-2. doi: 10.1016/j.urology.2017.07.032.
    note
    Source null
    related pmid
    28797683
    relationship
    Comment in
  3. citation
    N Engl J Med. ;377(17):1694-5. doi: 10.1056/NEJMc1711029.
    note
    Source null
    related pmid
    29083122
    relationship
    Comment in
  4. citation
    N Engl J Med. ;377(17):1695. doi: 10.1056/NEJMc1711029.
    note
    Source null
    related pmid
    29083123
    relationship
    Comment in
  5. citation
    N Engl J Med. ;377(17):1695-6. doi: 10.1056/NEJMc1711029.
    note
    Source null
    related pmid
    29083124
    relationship
    Comment in
  6. citation
    Cancer Biol Ther. 2018 Feb 1;19(2):97-100. doi: 10.1080/15384047.2017.1394555.
    note
    Source null
    related pmid
    29219670
    relationship
    Comment in
  7. citation
    J Urol. 2018 Jan;199(1):26-28. doi: 10.1016/j.juro.2017.10.007.
    note
    Source null
    related pmid
    29310181
    relationship
    Comment in
  8. citation
    Eur Urol. 2018 Jun;73(6):981. doi: 10.1016/j.eururo.2018.01.023.
    note
    Source null
    related pmid
    29433974
    relationship
    Comment in

Authors and identifiers

  1. name
    Fizazi K
    type
    Author
  2. name
    Tran N
    type
    Author
  3. name
    Fein L
    type
    Author
  4. name
    Matsubara N
    type
    Author
  5. name
    Rodriguez-Antolin A
    type
    Author
  6. name
    Alekseev BY
    type
    Author
  7. name
    Özgüroğlu M
    type
    Author
  8. name
    Ye D
    type
    Author
  9. name
    Feyerabend S
    type
    Author
  10. name
    Protheroe A
    type
    Author
  11. name
    De Porre P
    type
    Author
  12. name
    Kheoh T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fizazi K
    type
    Author
  2. name
    Tran N
    type
    Author
  3. name
    Fein L
    type
    Author
  4. name
    Matsubara N
    type
    Author
  5. name
    Rodriguez-Antolin A
    type
    Author
  6. name
    Alekseev BY
    type
    Author
  7. name
    Özgüroğlu M
    type
    Author
  8. name
    Ye D
    type
    Author
  9. name
    Feyerabend S
    type
    Author
  10. name
    Protheroe A
    type
    Author
  11. name
    De Porre P
    type
    Author
  12. name
    Kheoh T
    type
    Author
bibliography ids
  1. nci-bib-3ce476ab0579cd398344c28c
book metadata
content sha256
c8dd4262055d0760a9b58fe85cb9e1968da288cf08dba650bfdf4d9f29aa1d43
document type
citation
dois
  1. 10.1056/NEJMoa1704174
electronic publication date
display
2017 Jun 4
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28578607
immutable id
pubmed:28578607@c8dd4262055d0760a9b58fe85cb9e1968da288cf08dba650bfdf4d9f29aa1d43
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
4
name
The New England journal of medicine
nlm unique id
0255562
pages
352-360
volume
377
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Jul 27;377(4):388-390. doi: 10.1056/NEJMe1704992.
    note
    Source null
    related pmid
    28745978
    relationship
    Comment in
  2. citation
    Urology. 2017 Nov;109:1-2. doi: 10.1016/j.urology.2017.07.032.
    note
    Source null
    related pmid
    28797683
    relationship
    Comment in
  3. citation
    N Engl J Med. ;377(17):1694-5. doi: 10.1056/NEJMc1711029.
    note
    Source null
    related pmid
    29083122
    relationship
    Comment in
  4. citation
    N Engl J Med. ;377(17):1695. doi: 10.1056/NEJMc1711029.
    note
    Source null
    related pmid
    29083123
    relationship
    Comment in
  5. citation
    N Engl J Med. ;377(17):1695-6. doi: 10.1056/NEJMc1711029.
    note
    Source null
    related pmid
    29083124
    relationship
    Comment in
  6. citation
    Cancer Biol Ther. 2018 Feb 1;19(2):97-100. doi: 10.1080/15384047.2017.1394555.
    note
    Source null
    related pmid
    29219670
    relationship
    Comment in
  7. citation
    J Urol. 2018 Jan;199(1):26-28. doi: 10.1016/j.juro.2017.10.007.
    note
    Source null
    related pmid
    29310181
    relationship
    Comment in
  8. citation
    Eur Urol. 2018 Jun;73(6):981. doi: 10.1016/j.eururo.2018.01.023.
    note
    Source null
    related pmid
    29433974
    relationship
    Comment in
outcomes validated
false
pmid
28578607
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
e7836ccdda426cb9707bd5ddcfd0691d58348b3d8c925bcf8873c3ea5b8dc015
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Jul 27
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28578607/
title
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.

Preserved source evidence · Not medical advice